CoChat

Effectiveness of Short-Term Olanzapine in Patients With Bipolar I Disorder, With or Without Comorbidity With Substance Use Disorder

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Prognosis of comorbid bipolar disorder (BD) and drug abuse is poor. We assessed the efficacy of olanzapine in manic or mixed BD patients, with (SUD) or without (N-SUD) comorbidity with substance use disorder (SUD) and its effect on drug abuse, days of abuse, and craving. METHODS: Eighty patients with BD-I (40 SUD) were hospitalized for a manic or mixed episode and received add-on olanzapine. Assessments were conducted at admission, discharge, and 4 and 8 weeks after discharge. Primary outcome was the proportion of responders and remitters in each group. We used a logistic regression model to adjust for possible confounders. We assessed craving and drug-abuse days with a visual analog scale and the Timeline Follow-Back. RESULTS: SUD and N-SUD were similar on response and remission, adjusted for sex, age, years ill, age at first episode, first episode depressive, number of hospitalizations, and duration of hospitalization (odds ratio, 1.09; 95% confidence interval, 1.02-2.29). Mood rating scores dropped significantly from baseline to end point in both groups. Timeline follow-back decreased in SUD from 22.5 to 7.3 at 8 weeks postdischarge, whereas craving dropped from 8.3 to 5.1 (P < 0.03). CONCLUSIONS: The effectiveness of short-term olanzapine in BD-I mania or mixed mania did not differ according to SUD comorbidity. Treatment was followed by less substance use/abuse and craving in comorbid bipolar-SUD patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e318287019c

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 27

Metadata

Authors
Sani, G., Kotzalidis, G. D., Vöhringer, P., Pucci, D., Simonetti, A., Manfredi, G., Savoja, V., Tamorri, S. M., Mazzarini, L., Pacchiarotti, I., Telesforo, C. L., Ferracuti, S., Brugnoli, R., Ambrosi, E., Caloro, M., Del Casale, A., Koukopoulos, A. E., Vergne, D. E., Girardi, P., & Ghaemi, S. N.
Affiliations
  • Azienda Ospedaliera Sant'Andrea (IT)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
  • Tufts University (US)
  • Sapienza University of Rome (IT)
  • Fondazione Santa Lucia (IT)
  • Azienda Sanitaria Locale Viterbo (IT)
Corresponding author
  • Sani, Gabriele
  • Kotzalidis, Georgios D.
  • Pucci, Daniela
  • Simonetti, Alessio
  • Manfredi, Giovanni
  • Savoja, Valeria
  • Tamorri, Stefano Maria
  • Mazzarini, Lorenzo
  • Pacchiarotti, Isabella
  • Telesforo, Carla Ludovica
  • Ferracuti, Stefano
  • Brugnoli, Roberto
  • Ambrosi, Elisa
  • Caloro, Matteo
  • Koukopoulos, Alexia E.
  • Girardi, Paolo
Venue
Journal of Clinical Psychopharmacology
Published
2013-04
Volume
33
Issue
2
Pages
231-235
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2327033044
Cited by
27
References
46
Citations by year
2025: 1 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2 · 2015: 3 · 2014: 2
FWCI
1.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
olanzapine, bipolar I disorder, substance use comorbidity, manic episodes, mixed states, craving, mood stabilizers, treatment response and remission
MeSH terms
Olanzapine, Adult, Benzodiazepines, Bipolar Disorder, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Time Factors, Antipsychotic Agents, Logistic Models, Case-Control Studies, Treatment Outcome, Diagnosis, Dual (Psychiatry), Substance-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of Short-Term Olanzapine in Patients With Bipolar I Disorder, With or Without Comorbidity With Substance Use Disorder. https://app.cochat.ai/papers/10.1097/jcp.0b013e318287019c
The paper
Sani, G., Kotzalidis, G. D., Vöhringer, P., Pucci, D., Simonetti, A., Manfredi, G., Savoja, V., Tamorri, S. M., Mazzarini, L., Pacchiarotti, I., Telesforo, C. L., Ferracuti, S., Brugnoli, R., Ambrosi, E., Caloro, M., Del Casale, A., Koukopoulos, A. E., Vergne, D. E., Girardi, P., & Ghaemi, S. N. (2013). Effectiveness of Short-Term Olanzapine in Patients With Bipolar I Disorder, With or Without Comorbidity With Substance Use Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e318287019c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.